COMMUNIQUÉS West-GlobeNewswire

Shire plc : Rule 2.9 Announcement
30/05/2018
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. 30 May 2018 Shire [...]
ERYTECH to Webcast Presentation at the Jefferies Global Healthcare Conference
30/05/2018
LYON, France, May 30, 2018 (GLOBE NEWSWIRE) -- ERYTECH Pharma (Euronext Paris:ERYP) (Nasdaq: ERYP ) , a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating therapeutic drug [...]
FDA expedites review of Novartis drug Promacta® for first-line severe aplastic anemia (SAA)
30/05/2018
Promacta receives FDA Priority Review for first-line treatment of SAA based on data showing 52% complete response rate and 85% overall response rate when added to standard immunosuppressive therapy (IST) Regulatory [...]
Navamedic ASA: Q1 2018 results
30/05/2018
Oslo, May 30, 2018 - Navamedic ASA (OSE: NAVA) reported revenues of NOK 42.6 million in the first quarter of 2018, down from NOK 78.2 million in the same period in 2017, following the planned discontinuation of the [...]
INNATE PHARMA : Outcome of Annual General Meeting of May 29, 2018
30/05/2018
OUTCOME of ANNUAL GENERAL MEETING OF MAY 29, 2018 Marseille, France, May 30, 2018, 7:00 AM CEST Innate Pharma (Euronext Paris: FR0010331421 - IPH) announces the results of the voting by shareholders at the Annual [...]
INNATE PHARMA : Résultats de l'Assemblée Générale mixte du 29 mai 2018
30/05/2018
RÉSULTATS DE L'ASSEMBLÉE GÉNÉRALE MIXTE DU 29 MAI 2018 Marseille, le 30 mai 2018, 7h00 CEST Innate Pharma SA (Euronext Paris : FR0010331421 - IPH) annonce les résultats du vote des actionnaires à l'Assemblée générale [...]
Amicus Therapeutics Launches Galafold® (Migalastat) for Fabry Disease in Japan
30/05/2018
First Oral Precision Medicine for Fabry Patients with an Amenable Mutation Now Available in Japan CRANBURY, N.J. and TOKYO, May 30, 2018 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD ) has initiated the [...]
Intuitive to Begin Direct Operations in India
30/05/2018
Da Vinci® surgical systems manufacturer names general manager SUNNYVALE, Calif., May 29, 2018 (GLOBE NEWSWIRE) -- Intuitive Surgical, Inc., (Nasdaq: ISRG ) announced today it has begun direct operations in India, [...]
Assure Holdings Corp. Announces Update
30/05/2018
PARKER, Colo., May 29, 2018 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “ Company ” or “ Assure ”) (TSXV:IOM) (OTCQB:ARHH) is providing an update relating to the appointment of its new auditor and an update relating [...]
Telix Pharmaceuticals and Osaka University receive Japan Science and Technology Agency Funding for Alpha Nuclide Research
30/05/2018
KYOTO and OSAKA, Japan, May 30, 2018 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX:TLX) (“Telix”, the “Company”), a clinical-stage biopharmaceutical company focused on the development of diagnostic and [...]
Keryx Pharmaceuticals Announces Upcoming Investor Presentations
30/05/2018
BOSTON, May 29, 2018 (GLOBE NEWSWIRE) -- Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX ), a biopharmaceutical company focused on bringing innovative medicines to people with kidney disease, today announced two upcoming [...]
Surface Oncology Reports Financial Results and Corporate Highlights for First Quarter 2018
29/05/2018
Initiated a Phase 1 trial of SRF231, a fully human antibody targeting CD47 Completed upsized initial public offering and concurrent private placement raising a total of $119.5 million in gross proceeds CAMBRIDGE, Mass [...]
Dova Pharmaceuticals to Present at Jefferies 2018 Healthcare Conference
29/05/2018
DURHAM, N.C., May 29, 2018 (GLOBE NEWSWIRE) -- Dova Pharmaceuticals, Inc. (NASDAQ: DOVA ) today announced that Alex Sapir, President and Chief Executive Officer, will present a company overview at the Jefferies 2018 [...]
Kiniksa Pharmaceuticals, Ltd. Announces Closing of Initial Public Offering
29/05/2018
HAMILTON, Bermuda, May 29, 2018 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals, Ltd. (Nasdaq: KNSA ) (“Kiniksa”) announced today the closing of its initial public offering of 8,477,777 Class A common shares at a public [...]
Endocyte to Present at Jefferies Healthcare Conference
29/05/2018
WEST LAFAYETTE, Ind., May 29, 2018 (GLOBE NEWSWIRE) -- Endocyte, Inc. (Nasdaq: ECYT ), a biopharmaceutical company developing targeted therapeutics for personalized cancer treatment, today announced that the company’s [...]
Voyager Therapeutics Announces Management Change
29/05/2018
CAMBRIDGE, Mass., May 29, 2018 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (NASDAQ: VYGR ), a clinical-stage gene therapy company focused on developing life-changing treatments for severe neurological diseases today [...]
Cara Therapeutics to Present at the Jefferies 2018 Global Healthcare Conference
29/05/2018
STAMFORD, Conn., May 29, 2018 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq: CARA ), a biopharmaceutical company focused on developing and commercializing new chemical entities designed to alleviate pruritus and [...]
Oxford Immunotec to Present at the Jefferies 2018 Healthcare Conference
29/05/2018
OXFORD, United Kingdom and MARLBOROUGH, Mass., May 29, 2018 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq: OXFD ), a global, high-growth diagnostics company, today announced that Rick Altieri, Chief Financial [...]
T2 Biosystems Announces Proposed Public Offering of Common Stock
29/05/2018
LEXINGTON, Mass., May 29, 2018 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (Nasdaq: TTOO ), an emerging leader in the development and commercialization of innovative diagnostic products for critical unmet needs in [...]

Pages